Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem

• Published in: Antimicrobial agents and chemotherapy Vol. 59; no. 6; pp. 3406 - 3412
• Main Authors: Oteo, Jesús, Ortega, Adriana, Bartolomé, Rosa, Bou, Germán, Conejo, Carmen, Fernández-Martínez, Marta, González-López, Juan José, Martínez-García, Laura, Martínez-Martínez, Luis, Merino, María, Miró, Elisenda, Mora, Marta, Navarro, Ferran, Oliver, Antonio, Pascual, Álvaro, Rodríguez-Baño, Jesús, Ruiz-Carrascoso, Guillermo, Ruiz-Garbajosa, Patricia, Zamorano, Laura, Bautista, Verónica, Pérez-Vázquez, María, Campos, José
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.06.2015
• Subjects: Aged; Anti-Bacterial Agents; Anti-Bacterial Agents - pharmacology; Bacterial Proteins; Bacterial Proteins - metabolism; beta-Lactamases; beta-Lactamases - metabolism; Colistin; Colistin - pharmacology; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae - drug effects; Enterobacteriaceae - enzymology; Epidemiology and Surveillance; Escherichia coli; Escherichia coli - drug effects; Escherichia coli - enzymology; Humans; Klebsiella pneumoniae; Klebsiella pneumoniae - drug effects; Klebsiella pneumoniae - enzymology; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prospective Studies; Spain; Thienamycins; Thienamycins - pharmacology; Spain
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.00086-15

The aim of this study was to determine the impact of carbapenemase-producing Enterobacteriaceae (CPE) in Spain in 2013 by describing the prevalence, dissemination, and geographic distribution of CPE clones, and their population structure and antibiotic susceptibility. From February 2013 to May 2013, 83 hospitals (about 40,000 hospital beds) prospectively collected nonduplicate Enterobacteriaceae using the screening cutoff recommended by EUCAST. Carbapenemase characterization was performed by phenotypic methods and confirmed by PCR and sequencing. Multilocus sequencing types (MLST) were determined for Klebsiella pneumoniae and Escherichia coli. A total of 702 Enterobacteriaceae isolates met the inclusion criteria; 379 (54%) were CPE. OXA-48 (71.5%) and VIM-1 (25.3%) were the most frequent carbapenemases, and K. pneumoniae (74.4%), Enterobacter cloacae (10.3%), and E. coli (8.4%) were the species most affected. Susceptibility to colistin, amikacin, and meropenem was 95.5%, 81.3%, and 74.7%, respectively. The most prevalent sequence types (STs) were ST11 and ST405 for K. pneumoniae and ST131 for E. coli. Forty-five (54.1%) of the hospitals had at least one CPE case. For K. pneumoniae, ST11/OXA-48, ST15/OXA-48, ST405/OXA-48, and ST11/VIM-1 were detected in two or more Spanish provinces. ST11 isolates carried four carbapenemases (VIM-1, OXA-48, KPC-2, and OXA-245), but ST405 isolates carried OXA-48 only. A wide interregional spread of CPE in Spain was observed, mainly due to a few successful clones of OXA-48-producing K. pneumoniae (e.g., ST11 and ST405). The dissemination of OXA-48-producing E. coli is a new finding of public health concern. According to the susceptibilities determined in vitro, most of the CPE (94.5%) had three or more options for antibiotic treatment.